Previous studies by Roth & Majerus [J. Clin. Invest. (1975) 56, 624-632] showed that exposure of platelets to [acetyl-'4C]aspirin resulted in the radioactive labelling of three polypeptides, two of which were in the cytosol and not saturable, whilst the third was located in particulate material, and was saturated at 30 pM-aspirin. By using high voltage free flow electrophoresis to separate a platelet mixed membrane fraction into highly purified surface and intracellular membrane subfractions, we have confirmed that the major polypeptide acetylated after exposing whole platelets to [acetyl-'4C]aspirin is almost exclusively associated with intracellular membrane structures. We have shown previously that these intracellular membranes are the major site for prostanoid biosynthesis [Carey, Menashi & Crawford (1982) Biochem. J. 204, [847][848][849][850][851] and in the present study the extent of the radioactive labelling correlated well with inhibition of the cyclo-oxygenase activity in these intracellular membranes. In sodium dodecyl sulphate/polyacrylamide-gel electrophoresis the ['4C]acetylated component, which appears to be a dimer, migrates with a mobility corresponding to 72kDa. Although cyclo-oxygenase is inhibited, there is no discernible radioactive labelling when the platelets are exposed to aromatic-ring-labelled [14C]aspirin. We suggest that the site or sites for aspirin acetylation and cyclo-oxygenase activity are structurally associated in the platelet's intracellular membranes referred to by electron microscopists as the dense tubular membrane system. Aspirin is still unquestionably one of the widest used and most effective anti-inflammatory agents known, and this property, together with the more recently discovered action of maintaining blood platelet integrity, is believed to be due to an inhibitory effect upon certain prostanoid-synthesizing pathways. In the blood platelet the major site of this inhibitory action is the cyclo-oxygenase enzyme which converts long chain unsaturated fatty acids, and particularly arachidonic acid, to endoperoxides which are precursors for the biosynthesis of proaggregatory thromboxane. In earlier studies by it was demonstrated that exposure of platelets to Jacetyl-3H]aspirin resulted in the radioactive labelling by acetylation of three platelet proteins. Two of these acetylated proteins Abbreviation used: SDS, sodium dodecyl sulphate.
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were present in the platelet cytosol compartment and, under their experimental conditions, they were not saturable, whereas the third protein was associated with a high speed particulate fraction containing surface and intracellular membranes and the various platelet granular organelles. Acetylation of this particulate fraction protein (of apparent M, 85000) became saturated at 30pM-aspirin; the reaction was irreversible and complete within 20min. Although several earlier reports have identified the presence of the enzymes cyclooxygenase and thromboxane synthetase in platelets, and some have demonstrated their association with sedimentable particulate elements prepared from platelet homogenates (Hamberg et al., 1975; Hammarstr6m & Falardeau, 1977; Ho et al., 1976; Yoshimoto et al., 1977) , their exact subcellular localization was not established until recently. We developed a high-voltage free-flow electrophoresis procedure which enabled us Vol. 223 to separate from a human platelet mixed membrane fraction two subfractions of membrane vesicles representing surface and intracellular membranes. This differential isolation procedure allowed us to establish definitively that the intracellular membranes, referred to by electron microscopists as the dense tubular membrane system, are the predominant site of activity of the two enzymes cyclo-oxygenase and thromboxane synthase (Carey et al., 1982) . Our earlier demonstration that phospholipase A2 and diglyceride lipase activities were also associated with the same intracellular membrane elements (Lagarde et al., 1981) led us to propose that the complete enzymic machinery for the liberation of arachidonic acid from platelet membrane phospholipids and its subsequent conversion into endoperoxides and thromboxanes was a structurally integrated complex associated with endoplasmic reticulum-like intracellular membrane elements.
In this present paper we present further evidence for the localisation of platelet cyclo-oxygenase in intracellular membranes and show that, concomitant with its inhibition through exposure to aspirin at the whole cell level prior to subcellular fractionation, an intracellular membrane polypeptide of apparent M, 72000 is acetylated. Platelets were isolated from fresh buffy-coat packs kindly provided by the Transfusion Service Laboratory, Tooting, London, U.K.
Methods and materials
Processing was started in the laboratory within 3-4h of whole blood collection and all procedures were carried out at room temperature. The buffy coats were centrifuged at 200g for 20min and the supernatant platelet-rich plasma was removed and adjusted to pH 6.4 by the careful addition of 1 .OMcitric acid. The platelets were then sedimented (1800g, 20 min) and resuspended at a concentration of (2.5-10) x 108 platelets/ml in 10mM-Hepes [4-(2-hydroxyethyl)-1 -piperazine-ethanesulphonic acid] buffer, pH7.2, containing 0.15M-NaCl, 4mM-KCl and 3 mM-EDTA. Radiolabelled aspirin solubilized in this Hepes buffer was added to the cells at a final concentration of 48 HM in all experiments. The mixture was incubated at 37°C for 20min, and the platelets were again sedimented (1800g, 20min) and resuspended in the Hepes buffer to a similar cell concentration.
Membrane preparation and isolation of subfractions
The detailed procedure for the isolation and characterization of human platelet surface and intracellular membranes by using free-flow electrophoresis have been previously reported Lagarde et al., 1982) . Briefly, the method depends upon the reduction of the surface membrane electronegativity by exposing whole platelets to neuraminidase. Following this, a mixed membrane fraction is prepared from a platelet sonicate by using a sorbitol density gradient. This gradient fraction, which is free of contamination by granular organelles, is applied to the chamber of the free-flow-electrophoresis unit and the surface and intracellular membrane vesicles are separated discretely due to their difference in electrophoretic mobility. A level of 25 pg of leupeptin/ml is maintained throughout to minimize proteolysis. The fraction-collecting tubes containing the surface and intracellular membrane fractions were identified and characterized with the use of surface probes and marker enzymes as described earlier . The membrane subfractions have distinctive polypeptide and enzyme profiles and they differ significantly in phospholipid/cholesterol ratio, microviscosity, phospholipid classes and fatty acid composition (Lagarde et al., 1982) . SDS/polyacrylamide-gel electrophoresis and autoradiography Membranes were solubilized in 62.5mM-Tris/HCI, pH 6.8, containing 2-mercaptoethanol (5%, v/v), SDS (2%, w/v), glycerol (10%, v/v) and Bromophenol Blue (0.001%) by heating at 100°C for 5min. Samples were electrophoresed with a 10% resolving gel and a 3.3% stacking gel essentially according to the method of Laemmli (1970) . Gels were run at a constant current of 15 mA until the samples penetrated the resolving gel; the current was then increased to 2OmA until the dye front had migrated to within 5 mm of the end of the gel column. Staining was carried out in 0.25% Coomassie Brilliant Blue R250 in methanol/acetic acid/water (4:1: 5, by vol.) and destaining in methanol/acetic acid/water (4:1:5, by vol.) was continued until a clear background was visible. Gels were prepared for fluorography by treatment with En3Hance (New England Nuclear) and dried on a Bio-Rad slab gel dryer. They were then exposed to a pre-flashed Kodak X-Omat AR X-ray film at -76°C for 6 weeks. Development of the fluorographs were carried out according to manufacturer's recommended specifications. For gel calibration, the following standards were used: myosin heavy chain (200 kDa), phosphorylase a (94kDa), albumin (67kDa), ovalbumin (43kDa), soya bean trypsin inhibitor (29kDa) and a-iactalbumin (14kDa).
Cyclo-oxygenase activity
For the measurement of cyclo-oxygenase activity the fractions were incubated with 10gM-[1-14C]arachidonic acid for 10min at 25°C; after stopping the reaction by acidifying to pH 3.5 with 0.1 M-citric acid the radioactive metabolites were extracted into ethyl acetate and separated by t.l.c. for quantitative autoradiography. Heat-inactivated membranes similarly incubated with [1- 14C]arachidonic acid were included as enzyme controls. The full details of this assay have been reported earlier (Carey et al., 1982) and in the whole platelet experiments the contribution by [14C]-aspirin to the radioactivity present on the t.l.c. plates accounted for less than 1.0% of the total applied radioactivity. Time course of acetylation and cyclo-oxygenase inhibition using isolated intracellular membranes For the enzyme inhibition experiments using the isolated intracellular membrane vesicles the pooled fractions from the electrophoresis separation were centrifuged at 100lOOg for 60min and the membranes were resuspended in 50mM-Tris/HCl buffer, pH 7.4, to a protein concentration of approx. 1 mg/ml. An aliquot of this suspension was preincubated in the presence of 100 pM-aspirin at 25°C. At preincubation times of 0, 5, 10, 20, 30, 45 and 60min an aliquot was removed to another vessel and arachidonic acid was added to a concentration of 1O /M. These mixtures were incubated for a further 20min. The reaction was stopped by acidification to pH 3.5 with 0.1 M-citric acid and the metabolites were extracted as earlier described for the measurement of prostaglandin E2 by radioimmunoassay. In some experiments thromboxane B2 was also measured by a radioimmunoassay procedure.
In a parallel procedure, using a second aliquot of the intracellular membrane suspension, the incubations were carried out in the presence of 100 uM-[acetyl-14C]aspirin. After 0, 5, 10, 20, 30,  (Pinckard et al., 1968; De Furia et al., 1974; Hawkins et al., 1969) and it has also been established that such covalent modification leads to the formation of N-acetyl-lysine at a single site with albumin (Hawkins et al., 1969) and at multiple sites in the haemoglobin molecule (De Furia et al., 1974) . With respect to its action on platelet proteins, although a specific organelle target for acetylation was not identified, , using [acetyl-3H] aspirin, demonstrated significant incorporation of radioactivity into a particulate fraction prepared from platelet sonicates by centrifugation at 9 x 106g min.
In order to investigate the nature of the platelet intracellular organelles with which the aspirin-induced acetylation is associated, we have subfractionated sonicates of aspirin-treated platelets first into mixed membranes and granule fractions by using sorbitol gradient centrifugation and, following this, the mixed membrane fraction was further resolved by using free flow electrophoresis which gave separate vesicle populations of surface membrane and intracellular membrane origin. A typical free-flow-electrophoresis profile is presented in Fig. 1 Fraction no. The reductase is a marker for endoplasmic reticulum-like membranes. For simplicity the 125I-labelled Lens culinaris lectin data have not been plotted on this profile, but in all studies to date this label, applied at the whole-cell level before fractionation, is localized exclusively in the surface membrane fractions, with no detectable radioactivity in fractions below tube no. 37. The polarity of the electrophoresis chamber is represented on the diagram by the symbols e -and e. platelets from donors who had not taken aspirin during the previous 12 days. High intracellular membrane/surface membrane radioactivity ratios result from platelets in which these minor surface components had been acetylated by exposure to aspirin through previous oral intake.
Aliquots of equal protein content of the mixed, surface and intracellular-membrane fractions from [acetyl-14C]aspirin treated platelets were separated by one-dimensional SDS/polyacrylamide-gel electrophoresis. Staining with Coomassie Blue R250 and fluorography revealed (Fig. 2) that two major and closely migrating [I4C]acetylated polypeptides were present in the mixed membrane fraction, and by comparison with the mobility of Mr standards in the gel had an Mr of approx. 72000. Radiolabel specific activity was substantially increased in the intracellular membrane fraction with respect to mixed membranes and was barely detectable in the surface membrane fraction.
In an earlier report from this laboratory (Carey et al., 1982) it was shown that the specific activity (a) 10 3 X M 200 -T of the enzyme cyclo-oxygenase in the intracellular membranes of platelets was 5-fold enriched with respect to the activity in a mixed membrane fraction and depleted in the surface membrane fraction. These findings were consistent with the presence and enrichment of the [acetyl-'4C]aspirin label in the intracellular membranes described in the present study. To substantiate this further the cyclo-oxygenase activity was measured in the membrane subfractions isolated from paired aspirin-treated and control platelets. The results of this study are shown in Fig. 3 , where it can be seen that in the control platelets the activity of the cyclooxygenase is 10-fold higher in the intracellular membrane fraction as compared with the surface membrane, and these activities were respectively 93% and 84% inhibited in the intracellular membrane and surface membrane fractions from the aspirin-treated cells. 14C]aspirin for periods ranging from 5 to 60min. The rate of acetylation is rapid over the first 1 min (reaching 88% of maximum). Thereafter it is slower but by 60min all available acetylation sites appear to be occupied. Table 2 shows the percentage inhibition of arachidonic acid metabolite production (prostaglandin E2 and thromboxane B,) by the intracellular membrane enzyme(s) when the substrate was added after varying periods of preincubation with aspirin. It is clear from these data that after 60min preincubation of membrane vesicles with aspirin, a time at which acetylation of membrane protein is complete (see Fig. 4 only around 50% inhibited after 60min pre-exposure to 100pM-aspirin. At present we have no definitive explanation for this apparent anomaly, but it is possible that within the membrane microenvironment there may be enzyme active sites that are accessible to arachidonic acid but not readily reached by acetylsalicylic acid. Such a phenomenon may result from the various procedures to which the enzyme is exposed during isolation of the purified intracellular membrane elements from the platelet homogenate. It is clear, however, that the progress of the acetylation process and the increasing inhibition of the enzymes relate to the extent of exposure to the aspirin during the preincubations.
In conclusion, therefore, using highly purified preparations of surface and intracellular membranes from [acetyl-14C] aspirin-treated platelets, we have identified the major polypeptide target for acetylation as almost exclusively localized in the intracellular membranes. Exposure to the [acetyl-14C] aspirin results in the labelling of two polypeptides of closely similar mobilities and of approximate M, 72000. These results extend the studies of , who localized the target for aspirin acetylation to a particulate fraction prepared from platelet sonicates. In the present studies there was no incorporation of radioactivity into protein when platelets were exposed to [carboxyl-14C] aspirin, suggesting that there was no transfer to the protein of the salicylic acid moiety and that the binding involved the acetyl group present in the aspirin molecule. Our finding of a 72 kDa major acetylated polypeptide agrees well with the value (70 kDa) quoted by Roth (1981) in his revieW paper, although a slightly higher value of 85 kDa was reported in their earlier studies . The incorporation of the [14C]acetyl group into intracellular membrane protein has been followed over a time course 0-60min. Maximum acetylation occurs between 40 and 60min incubation with 100 M-aspirin, with some variation within this range for different platelet membrane preparations. However, at maximum incorporation of the [I4C]acetyl moiety the formation of metabolites from added arachidonic acid is only around 50% inhibited. The relationship with time between these two parameters supports our view that the 72kDa component seen in the autoradiographs is an integral part of the enzyme complex and its acetylation strongly interferes with the active site involved in prostaglandin endoperoxide biosynthesis.
